M&A Deal Summary |
|
---|---|
Date | 1999-07-07 |
Target | Angioguard |
Sector | Medical Products |
Buyer(s) | Cordis |
Sellers(s) |
Arcade Partners
SightLine Partners |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1966 |
Sector | Medical Products |
Revenue | 780M USD (2014) |
Cordis is a provider of cardiovascular and endovascular medical devices. Founded in 1966, the Company has a long history of innovation in high-quality and minimally-invasive cardiovascular technology. Its products are primarily used in procedures to diagnose and treat the narrowing or blockage of arteries. Cordis was founded in 1966 and is based in Miami Lakes, Florida.
DEAL STATS | # |
---|---|
Overall | 1 of 4 |
Sector (Medical Products) | 1 of 3 |
Type (Add-on Acquisition) | 1 of 4 |
State (Minnesota) | 1 of 1 |
Country (United States) | 1 of 3 |
Year (1999) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2005-09-28 |
LuMend
Redwood City, California, United States LuMend, Inc. develops a full range of advanced product platforms that target chronic total occlusions in the rapidly growing peripheral vascular market. The company is focused on delivering technology and services to interventional cardiologists, radiologists and vascular surgeons specializing in endovascular techniques for the treatment of peripheral vascular disease. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 2003 |
Size | Small |
Type | Sector Agnostic |
Arcade Partners is a private investment partnership that targets middle market buyouts and recapitalizations. Arcade seeks light manufacturing and service based businesses with recurring revenues. Arcade targets profitable companies with minimum EBITDA of $4 to $25 million. Arcade Partners is based in West Hartford, Connecticut.
DEAL STATS | # |
---|---|
Overall | 2 of 6 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 2 of 3 |
State (Minnesota) | 1 of 1 |
Country (United States) | 2 of 6 |
Year (1999) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
1998-03-09 |
American Cellular corp.
Franklin, Tennessee, United States American Cellular was one of the largest independent rural cellular telephone system operators in the U.S. The Company owned and operated non-wireline FCC-licensed cellular telephone systems primarily in rural areas of the Midwestern and Eastern portions of the U.S. American Cellular was acquired by a joint venture between AT&T and Dobson. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2000-02-26 |
American Cellular corp.
Franklin, Tennessee, United States American Cellular was one of the largest independent rural cellular telephone system operators in the U.S. The Company owned and operated non-wireline FCC-licensed cellular telephone systems primarily in rural areas of the Midwestern and Eastern portions of the U.S. American Cellular was acquired by a joint venture between AT&T and Dobson. |
Sell | $2.4B |
Category | Growth Capital Firm |
---|---|
Founded | 2004 |
Size | Small |
Type | Sector Focused |
SightLine Partners is a private investment firm that targets early to late stage investments in growing healthcare and medical technology companies. Depending on the maturity of the company, Sightline will invest between $2 and $8 million per transaction. SightLine prefers US based opportunities. SightLine Partners LLC was formed in 2004 and is based in Minneapolis, Minnesota.
DEAL STATS | # |
---|---|
Overall | 3 of 16 |
Sector (Medical Products) | 3 of 15 |
Type (Add-on Acquisition) | 2 of 12 |
State (Minnesota) | 1 of 5 |
Country (United States) | 3 of 16 |
Year (1999) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
1997-12-01 |
Endovascular Technologies
Menlo Park, California, United States Endovascular Technologies, Inc. is a designer and manufacturer of minimally invasive endovascular systems to repair diseased or damaged vascular structures. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
1999-09-01 |
Exogen
Piscataway, New Jersey, United States Exogen, Inc. provides medical technologies focused on the biophysical treatment of musculoskeletal injury and disease. |
Sell | - |